Projects per year
Abstract
Mucosal-associated invariant T (MAIT) cells can elicit immune responses against riboflavin-based antigens presented by the evolutionary conserved MHC class I related protein, MR1. While we have an understanding of the structural basis of human MAIT cell receptor (TCR) recognition of human MR1 presenting a variety of ligands, how the semi-invariant mouse MAIT TCR binds mouse MR1-ligand remains unknown. Here, we determine the crystal structures of 2 mouse TRAV1-TRBV13-2+ MAIT TCR-MR1-5-OP-RU ternary complexes, whose TCRs differ only in the composition of their CDR3β loops. These mouse MAIT TCRs mediate high affinity interactions with mouse MR1-5-OP-RU and cross-recognize human MR1-5-OP-RU. Similarly, a human MAIT TCR could bind mouse MR1-5-OP-RU with high affinity. This cross-species recognition indicates the evolutionary conserved nature of this MAIT TCR–MR1 axis. Comparing crystal structures of the mouse versus human MAIT TCR-MR1-5-OP-RU complexes provides structural insight into the conserved nature of this MAIT TCR–MR1 interaction and conserved specificity for the microbial antigens, whereby key germline-encoded interactions required for MAIT activation are maintained. This is an important consideration for the development of MAIT cell-based therapeutics that will rely on preclinical mouse models of disease.
Original language | English |
---|---|
Article number | 107229 |
Number of pages | 12 |
Journal | Journal of Biological Chemistry |
Volume | 300 |
Issue number | 5 |
DOIs | |
Publication status | Published - May 2024 |
Keywords
- 5-OP-RU
- antigen presentation
- MHC-related molecule (MR1)
- mouse MAIT TCR
- protein structure
Projects
- 1 Active
-
ARC Centre of Excellence for Innovations in Peptide and Protein Science
Craik, D. J. (Primary Chief Investigator (PCI)), Payne, R. J. (Chief Investigator (CI)), Belov, K. (Chief Investigator (CI)), Jolliffe, K. A. (Chief Investigator (CI)), New, E. (Chief Investigator (CI)), Fairlie, D. P. (Chief Investigator (CI)), King, G. F. (Chief Investigator (CI)), Henriques, S. T. (Chief Investigator (CI)), Otting, G. (Chief Investigator (CI)), Malins, L. (Chief Investigator (CI)), Jackson, C. (Chief Investigator (CI)), Cryle, M. (Chief Investigator (CI)), Challis, G. (Chief Investigator (CI)), Colgrave, M. (Chief Investigator (CI)), Ploegh, H. (Partner Investigator (PI)), Baker, D. A. (Partner Investigator (PI)), Suga, H. (Partner Investigator (PI)), Davis, B. G. (Partner Investigator (PI)), Pentelute, B. (Partner Investigator (PI)), van der Donk, W. (Partner Investigator (PI)), Tavassoli, A. (Partner Investigator (PI)) & Savage, G. (Partner Investigator (PI))
23/12/20 → 21/01/28
Project: Research
Equipment
-
Australian Synchrotron
Office of the Vice-Provost (Research and Research Infrastructure)Facility/equipment: Facility
-
Macromolecular Crystallisation Facility
Kong, G. (Operator)
Faculty of Medicine Nursing and Health Sciences Research PlatformsFacility/equipment: Facility